| mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
Imatinib |
FIMM |
pan-cancer |
AAC |
-0.017 |
0.9 |
| mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
Sunitinib |
FIMM |
pan-cancer |
AAC |
-0.016 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |